RRM2 and acute myeloid leukemia: In addition, knockdown of RRM2 alone with specific shRNAs (Figure 3J,K) enhanced the RNR inhibitory effects of MB, as shown by the S phase arrest analyses in AML cells (Figure 3L,M), supporting the hypothesis that targeting intracellular RRM2 might inhibit AML malignant behaviours.